1. Howlader N NA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). : SEER Cancer Statistics Review, 1975–2013, National Cancer Institute.. In., Based on November 2015 SEER data submission, posted to the SEER web site. edn. Bethesda, MD,
http://seer.cancer.gov/csr/1975_2013/
; April 2016.
2. Bernier J. 1950- éditeur intellectuel SpringerLink (service en ligne): head and neck cancer : multimodality management. Switzerland: Springer; 2016.
3. Halperin ECP, Carlos A, 1934- Ovid Technologies, Inc. Perez and Brady's principles and practice of radiation oncology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2013.
4. Morris LG, Sikora AG, Hayes RB, Patel SG, Ganly I. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control. 2011;22(5):671–9.
5. Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;